Medtronic

MDT

Market cap $94.8B

Medtronic shares have declined ~25% since February amid sector headwinds and a disappointing MiniMed spin-off. Recent bolt-on acquisitions—SPR Therapeutics, CathWorks, and Scientia Vascular—signal Medtronic's focus on innovation and future growth. At $75, Medtronic trades at 13–14x adjusted FY2026 earnings guidance, with a dividend yield near 4%.

Get a deeper insight into the potential performance of Medtronic (MDT) for the quarter ended April 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.

Medtronic (MDT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

In the closing of the recent trading day, Medtronic (MDT) stood at $77.6, denoting a -1.27% move from the preceding trading day.

ISRG is widening its robotic surgery lead with faster growth, rising procedures and a recurring revenue model as Medtronic builds Hugo.

Historically, energy stocks have performed the best when inflation spikes.

Medtronic's Q4 results may get a lift from broad MedSurg growth, strong Cardiovascular demand and continued momentum in Diabetes.

Barron's Oil & Blue Chip Tips for May 2026 highlight 20 stocks, with 11 deemed 'safer' based on free cash flow yields exceeding dividend yields. Top ten by yield are projected to deliver average net gains of 36.08% by May 2027, with risk/volatility 24% below the market average. Zoetis (ZTS), Danaher (DHR), and Accenture (ACN) lead in projected returns, with ZTS estimated to net 60.33% and lower-than-market volatility.

Medtronic eyes a $650 million acquisition of SPR, adding the FDA-cleared SPRINT PNS System to expand its chronic pain treatment offerings ahead of the fiscal 2027 closing.

The first list of 8 companies that could reach Dividend King status in coming years. These companies provide investors a wide range of starting dividend yields and growth histories. It's possible one or more of these companies do not attain Dividend King status.